AUTL

Autolus Therapeutics
AUTL

Overview Fund Activity

70 hedge funds and large institutions have $204M invested in Autolus Therapeutics in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
70
Holders Change
+4
Holders Change %
+6.06%
% of All Funds
1.13%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
20
Increased
23
Reduced
12
Closed
15
Calls
$334K
Puts
$3K
Net Calls
+$331K
Net Calls Change
+$137K

Top Buyers

1
DTC
1
Deep Track Capital
Connecticut
$28.5M
2
SP
2
Syncona Portfolio
Guernsey
$40.6M
3
AC
3
Armistice Capital
New York
$19.4M
4
TAM
4
TFG Asset Management
Cayman Islands
$15.8M
5
NCM
5
Nantahala Capital Management
Connecticut
$14.8M

Top Sellers

1
UOC
1
UBS O'Connor
Illinois
$0
2
WP
2
Woodline Partners
California
$0
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$2.15K
4
MA
4
MYDA Advisors
New York
$0
5
KHCM
5
Kettle Hill Capital Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
AA
76
ALPS Advisors
Colorado
– -$106K -49,657 Closed
GCP
77
GSA Capital Partners
United Kingdom
– -$49K -22,885 Closed
NFC
78
Northeast Financial Consultants
Connecticut
– -$42K -19,672 Closed
Jane Street
79
Jane Street
New York
– -$41K -19,289 Closed
Goldman Sachs
80
Goldman Sachs
New York
– -$40K -18,851 Closed
WMSA
81
Weiss Multi-Strategy Advisers
New York
– -$29K -13,324 Closed
US Bancorp
82
US Bancorp
Minnesota
– -$16K -7,652 Closed
CUAMC
83
China Universal Asset Management Company
China
– -$1K -542 Closed
1 2 3
4